Source: University of Notre Dame From: sciencedaily.com The American Cancer Society estimates that 284,200 women will be newly diagnosed with breast cancer in 2021, and 43,600 will die of the disease — the second highest cause of cancer death in women. A woman’s risk of being diagnosed with breast cancer increases with age, but while scientists have long studied cellular …
Common cholesterol drugs could slow spread of breast cancer to brain
By: Deanna Csomo McCool, University of Notre Dame From: medicalxpress.com A new study from the University of Notre Dame shows drugs used to treat high cholesterol could interfere with the way breast cancer cells adapt to the microenvironment in the brain, preventing the cancer from taking hold. Patients with breast cancer who experience this type of metastasis typically survive for …
Zhang group identifies gene that may make triple-negative breast cancer cells vulnerable to existing drug
Source: University of Notre Dame From: newswise.com Certain therapies that have proven effective in treating some types of breast cancers are ineffective for women diagnosed with triple-negative breast cancer (TNBC). In fact, there is limited targeted drug therapy for this type of breast cancer — the most aggressive type, diagnosed in about 20 percent of breast cancer patients. But a …
How one enzyme could stop the spread of cancer
By: Catharine Paddock PhD From: medicalnewstoday.com Scientists have identified a new enzyme mechanism that induces cancer cells that are about to migrate to destroy themselves by degrading their tiny powerhouses, or mitochondria. They hope that this discovery will lead to new treatments that can stop tumors from spreading. The process through which cancer cells break free of their primary sites …
Scientists identify potential new treatment for pancreatic cancer
By: Ryan Maass From: upi.com Researchers at the University of Notre Dame say they have uncovered a new approach for treating pancreatic cancer. In a study led by Notre Dame professor Reginald Hill, medical scientists focused on FDA-approved drugs to find out why many of them don’t work on pancreatic cancer. The team found that blocking the release of exosomes …